Heather J. Ross

Transforming growth factor-beta expression is significantly lower in hearts preserved with blood/insulin versus crystalloid cardioplegia.

Mechanical circulatory assistance: state of art.

Donor management in cardiac transplantation.

Hyperhomocysteinemia in heart transplantation: from bench to bedside.

An interactive Internet site for the management of patients with congestive heart failure.

Effects of folic acid fortification and multivitamin therapy on homocysteine and vitamin B(12) status in cardiac transplant recipients.

Explantation of a mechanical assist device: assessment of myocardial recovery.

Genetic polymorphisms predisposing to hyperhomocysteinemia in cardiac transplant patients.

Use of basiliximab and cyclosporine in heart transplant patients with pre-operative renal dysfunction.

Tetrahydrobiopterin prevents cyclosporine-induced vasomotor dysfunction.

Increased ventricular repolarization heterogeneity in patients with ventricular arrhythmia vulnerability and cardiomyopathy: a human in vivo study.

Monitoring of cyclosporine 2-hour post-dose levels in heart transplantation: improvement in clinical outcomes.

Cardiac allograft vasculopathy: a review.

Thromboembolism in heart transplantation: role of prothrombin G20210A and factor V Leiden.

Withdrawal of ventricular assist device support.

Effect of vasopressin on hemodynamics in patients with refractory cardiogenic shock complicating acute myocardial infarction.

Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management.

Role of endothelin-1 and nitric oxide bioavailability in transplant-related vascular injury: comparative effects of rapamycin and cyclosporine.

Elevated endothelin-1 levels impair nitric oxide homeostasis through a PKC-dependent pathway.

Racial and ethnic variations in albuminuria in the US Third National Health and Nutrition Examination Survey (NHANES III) population: associations with diabetes and level of CKD.

Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers.

Proliferation signal inhibitors in cardiac transplantation.

Orthotopic cardiac transplantation in a patient with pectus excavatum: approach via left anterior thoracotomy.

Endothelin-1 accentuates the proatherosclerotic effects associated with C-reactive protein.

The dilemma of a left ventricular assist device explantation: a decision analysis.

An unusual complication of support with a continuous-flow cardiac assist device.

Sirolimus-based immunosuppression after cardiac transplantation: predictors of recovery from calcineurin inhibitor-induced renal dysfunction.

Mycophenolate mofetil dose reduction for gastrointestinal intolerance is associated with increased rates of rejection in heart transplant patients.

Canadian Cardiovascular Society Consensus Conference guidelines on heart failure--2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies.

Myocardial HLA-G reliably indicates a low risk of acute cellular rejection in heart transplant recipients.

Pathological findings in explanted prosthetic heart valves from ventricular assist devices.

Choices: a study of preferences for end-of-life treatments in patients with advanced heart failure.

Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials.

Trying to succeed when the right ventricle fails.

The impact of everolimus versus mycophenolate on blood and lymphocyte cyclosporine exposure in heart-transplant recipients.

Donor aortic root dilation.

Renal-sparing strategies in cardiac transplantation.

Generic drug immunosuppression in thoracic transplantation: an ISHLT educational advisory.

Usefulness of the INTERMACS scale to predict outcomes after mechanical assist device implantation.

Recurrent cardiac amyloidosis following previous heart transplantation.

Everolimus but not mycophenolate mofetil therapy is associated with soluble HLA-G expression in heart transplant patients.

Predictors of acute renal dysfunction after ventricular assist device placement.

Correlation between circulating endothelial progenitor cell function and allograft rejection in heart transplant patients.

Pregnancy outcomes in women with dilated cardiomyopathy.

Association between HLA-G expression and C4d staining in cardiac transplantation.

Cardiac resynchronization therapy after atrioventricular node ablation for rapid atrial fibrillation in a heart transplant recipient with late allograft dysfunction.

Pain after heart transplantation: prevalence and implications for quality of life.

Impact of fixed pulmonary hypertension on post-heart transplant outcomes in bridge-to-transplant patients.

Everolimus: efficacy and safety in cardiac transplantation.

Epidermal growth factor-like domain 7 suppresses intercellular adhesion molecule 1 expression in response to hypoxia/reoxygenation injury in human coronary artery endothelial cells.

Cardiac sarcoidosis: recurrent disease in a heart transplant patient following pulmonary tuberculosis infection.

Endothelin-1 antagonism and nitric oxide augmentation prevents cyclosporine-induced vasomotor impairment.

Mechanical circulatory support with the ABIOMED BVS 5000: the Toronto General Hospital experience.

Attitudes of heart failure patients and health care providers towards mobile phone-based remote monitoring.

The North Pole: a heart transplant first.

Self-care and quality of life of heart failure patients at a multidisciplinary heart function clinic.

Tacrolimus preserves vasomotor function and maintains vascular homeostasis.

Letter by Burchill et al regarding article, "Enalapril in infants with single ventricle: results of a multicenter randomized trial".

Both patient and caregiver gender impact depressive symptoms among organ transplant caregivers: who is at risk and why?

How aware of advanced care directives are heart failure patients, and are they using them?

Qualitative interviews vs standardized self-report questionnaires in assessing quality of life in heart transplant recipients.

Quality of life for patients supported on a left ventricular assist device.

The effect of ventricular assist devices on long-term post-transplant outcomes: a systematic review of observational studies.

Comparison of hospitalized solid organ transplant recipients and nonimmunocompromised patients with pandemic H1N1 infection: a retrospective cohort study.

The 2011 Canadian Cardiovascular Society heart failure management guidelines update: focus on sleep apnea, renal dysfunction, mechanical circulatory support, and palliative care.

Mechanical circulatory support as a bridge to transplant candidacy.

Epidermal growth factor-like domain 7 is a novel inhibitor of neutrophil adhesion to coronary artery endothelial cells injured by calcineurin inhibition.

Human leukocyte antigen-G is upregulated in heart failure patients: a potential novel biomarker.

The Heart Failure Society of America in 2020: a vision for the future.

Perceptions and experiences of heart failure patients and clinicians on the use of mobile phone-based telemonitoring.

Mobile phone-based telemonitoring for heart failure management: a randomized controlled trial.

Heart transplantation in adults with end-stage congenital heart disease.

Highly sensitized patients in cardiac transplantation: early outcomes from the Canadian Prioritized Organ Sharing Program.

Developing healthcare rule-based expert systems: case study of a heart failure telemonitoring system.

Antibody-mediated rejection: an evolving entity in heart transplantation.

A sensitive approach.

Quality of life and left ventricular assist device support.

Circulating proangiogenic progenitor cells independently predict functional capacity in heart failure patients.

The 2012 Canadian Cardiovascular Society Heart Failure Management Guidelines Update: Focus on Acute and Chronic Heart Failure.

Concordance among pathologists in the second Cardiac Allograft Rejection Gene Expression Observational Study (CARGO II).

Can HLA-G polymorphisms predict the development of cardiac allograft vasculopathy?

Central sleep apnea interfering with adequate left ventricular filling in a patient with left ventricular assist device.

Outcomes and care of patients with acute heart failure syndromes and cardiac troponin elevation.

Cost-effectiveness of ventricular assist device therapy as a bridge to transplantation compared with nonbridged cardiac recipients.

Clinical differences between continuous flow ventricular assist devices: a comparison between HeartMate II and HeartWare HVAD.

Risk prediction models for mortality in ambulatory patients with heart failure: a systematic review.

Changes in circulating progenitor cells are associated with outcome in heart failure patients: a longitudinal study.

Predictors of mortality in patients with an implantable cardiac defibrillator: a systematic review and meta-analysis.

Association of heart rate at hospital discharge with mortality and hospitalizations in patients with heart failure.

The 2013 Canadian Cardiovascular Society Heart Failure Management Guidelines Update: focus on rehabilitation and exercise and surgical coronary revascularization.

Right ventricular function and prognosis in stable heart failure patients.

"Please Sir, I want some more?"… Charles Dickens, Oliver Twist.

Using heart failure instruments to determine when to refer heart failure patients to palliative care.

A contemporary review of adult heart transplantation: 2012 to 2013.

Impact of adult congenital heart disease on survival and mortality after heart transplantation.

A randomized pilot trial of remote ischemic preconditioning in heart failure with reduced ejection fraction.

Native and prosthetic valve infective endocarditis: clinicopathologic correlation and review of the literature.

Ischemic electrocardiographic abnormalities and prognosis in decompensated heart failure.

Heart transplants: Identity disruption, bodily integrity and interconnectedness.

The 2014 Canadian Cardiovascular Society Heart Failure Management Guidelines Focus Update: anemia, biomarkers, and recent therapeutic trial implications.

Factors associated with anti-human leukocyte antigen antibodies in patients supported with continuous-flow devices and effect on probability of transplant and post-transplant outcomes.

C4d immunostaining is an independent predictor of cardiac allograft vasculopathy and death in heart transplant recipients.

The ethics of risk and innovation.

Renin-angiotensin-aldosterone system genotype and serum BNP in a contemporary cohort of adults late after Fontan palliation.

Tricuspid Valve Annular Dilation as a Predictor of Right Ventricular Failure After Implantation of a Left Ventricular Assist Device.

The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update.

Mitral clip - looking back and moving forward.

Chronic Heart Failure in Congenital Heart Disease: A Scientific Statement From the American Heart Association.

Transplantation and Mechanical Circulatory Support in Congenital Heart Disease: A Scientific Statement From the American Heart Association.

Generation of Antigen Microarrays to Screen for Autoantibodies in Heart Failure and Heart Transplantation.

Perfusion Cardiac Magnetic Resonance Imaging as a Rule-Out Test for Cardiac Allograft Vasculopathy.

Response to Cornelis et al Regarding Article: "The Added Value of Exercise Variables in Heart Failure Prognosis".

Care Setting Intensity and Outcomes After Emergency Department Presentation Among Patients With Acute Heart Failure.

Chronic congestive heart failure - a new therapeutic choice.

Emerging imaging techniques after cardiac transplantation.